The detection of both SARS‐CoV‐2 IgM/IgG (convalescent phase) and SARS‐CoV‐2‐spike protein (acute phase) could increase the diagnostic window, that is, from the early stage to 7 or 10 days of infection. This evidence concerns the gene CD40LG and infection.